Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
20 Cards in this Set
- Front
- Back
What is the mechanism of action for sulfonamides?
|
Sulfonamides mimic PABA and compete with PABA for binding to dihydropteroate synthase
- sulfonamides will inhibit dihydropteroate synthase so that folic acid cannot be made for the bacteria - will inhibit growth but not kill = bacteriostatic |
|
What is the mechanism of resistance to sulfonamides?
|
bacteria can either...
- change dihydropteroate synthase so that sulfas can't bind - increase production of PABA so the sulfas are out-competed There is actually widespread resistance to sulfonamides so these are NOT used alone to treat infections |
|
What is the absorption of sulfonamides?
|
Oral
|
|
What is the distrubution of sulfonamides?
|
- goes to all tissues including CSF!
(in the past sulfas were used to treat meningitis, but not anymore because of the resistance) |
|
Metabolism of sulfonamides?
|
Liver; with variable half life
|
|
Excretion of sulfonamides
|
- mostly glomerular filtration
- achieve high concentration in urine (why they are good to help treat UTIs!) |
|
Describe the synergistic activity of sulfamethoxazole and trimethoprim
|
When TMP and SMX are given together you need less than half of each drug to achieve MIC
- basically they are more effective together (beyond an additive effect) |
|
Why was sulfamethoxazole chosen for a combination with trimethoprim?
|
- synergistic antibacterial activity
- when used alone experience widespread resistance - both have a similar half life (11 hrs) - can tx gram + and - - good for UTIs, RTIs, Shigella - effective with 3 day dosing |
|
What is the difference between sulfonamides and trimethoprim?
|
sulfonamides inhibit dihydropteroate synthase and trimethoprim inhibits dihydrofolate reductase
|
|
What are the limitations to the use of sulfonamides?
|
experience widespread resistance when used alone
|
|
Adverse effects of sulfonamides
|
- crystalline aggregates in urine
- hematologic disorders - hypersensitivity (skin rash is common) - GI irritation |
|
Why might you need to watch out for patients with G6PD deficiency if you administer sulfonamides?
|
- sulfonamides can cause acute hemolytic anemia (destroy erythrocytes) in patients with G6PD deficiency
- this is particularly common in malaria prone regions |
|
What must be considered if administering sulfonamides / trimethoprim with warfarin?
|
- warfarin is metabolized by CYP enzymes
- both sulfas and trimethoprim inhibit (different) cyp enzymes - leads to a potentiation effect on the activity of warfarin ... basically the drug (warfarin) will build up because it is not being broken down by cyp |
|
What is the mechanism of action for trimethoprim?
|
- inhibits bacterial folate synthesis
- will inhibit the enzyme dihyrofolate reductase (DHFR) - this enzyme is common to bacteria and humans, but trimethoprim is much more selective for the bacterial form of DHFR |
|
What are the mechanisms of resistance to trimethoprim
|
- bacteria can increase the production of DHFR (make too much enzyme for the drug to inhibit)
- can change the DHFR enzyme so that the drug can no longer bind as well |
|
Absorption of trimethoprim
|
oral
|
|
distribution of trimpethoprim
|
- goes pretty much anywhere, will penetrate the CSF
(like sulfas not used to treat meningitis anymore because of resistance) |
|
metabolism of trimethoprim
|
- minimally metabolized
- 11 hour t1/2 |
|
excretion of trimethoprim
|
renally excreted and will build up in urine
|
|
Adverse rxns of TMP / SMX combo
|
- derm reactions (itchy!!)
- be careful in folate-deficient patients... - be careful with AIDS patients... - GI disturbances |